These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15304458)

  • 1. Effects of estrogen-only treatment in postmenopausal women.
    Campagnoli C; Abbà C; Ambroggio S; Peris C
    JAMA; 2004 Aug; 292(6):684; author reply 685-6. PubMed ID: 15304458
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogen-only treatment in postmenopausal women.
    Perlroth FA
    JAMA; 2004 Aug; 292(6):685; author reply 685-6. PubMed ID: 15304461
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of estrogen-only treatment in postmenopausal women.
    Kerlikowske K; Miglioretti DL
    JAMA; 2004 Aug; 292(6):684-5; author reply 685-6. PubMed ID: 15304459
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of estrogen-only treatment in postmenopausal women.
    Meyer VF
    JAMA; 2004 Aug; 292(6):683-4; author reply 685-6. PubMed ID: 15304457
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of estrogen-only treatment in postmenopausal women.
    Kuhl H
    JAMA; 2004 Aug; 292(6):683; author reply 685-6. PubMed ID: 15304455
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of estrogen-only treatment in postmenopausal women.
    Cooper MH
    JAMA; 2004 Aug; 292(6):685; author reply 685-6. PubMed ID: 15304462
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of estrogen-only treatment in postmenopausal women.
    Beral V; Banks E; Reeves G;
    JAMA; 2004 Aug; 292(6):684; author reply 685-6. PubMed ID: 15304460
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of estrogen-only treatment in postmenopausal women.
    Rookus MA; van Leeuwen FE
    JAMA; 2004 Aug; 292(6):683; author reply 685-6. PubMed ID: 15304456
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women.
    Malarkey WB; Burleson M; Cacioppo JT; Poehlmann K; Glaser R; Kiecolt-Glaser JK
    Endocrine; 1997 Oct; 7(2):227-33. PubMed ID: 9549049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
    Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 12. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
    Håkan Wallén N; Li N; Eriksson-Berg M; Landgren BM; Schenck-Gustafsson K; Hjemdahl P
    Thromb Haemost; 2006 Dec; 96(6):862-3. PubMed ID: 17139389
    [No Abstract]   [Full Text] [Related]  

  • 14. Sympathetic skin response in women receiving hormone replacement therapy.
    Kutlar I; Yilmaz M; Balat O
    Int J Gynaecol Obstet; 2004 Feb; 84(2):181-2. PubMed ID: 14871527
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a].
    Mendoza S; Velazquez E; Osona A; Hamer T; Glueck CJ
    J Lab Clin Med; 1994 Jun; 123(6):837-41. PubMed ID: 8201261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue.
    Shadoan MK; Kavanagh K; Zhang L; Anthony MS; Wagner JD
    Metabolism; 2007 Jun; 56(6):830-7. PubMed ID: 17512317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.